<!DOCTYPE html>
<html xmlns:og="http://opengraphprotocol.org/schema/">
    <head>
        <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no">
        <meta http-equiv="content-type" content="text/html; charset=utf-8" />
        <title>	2023-06029 - PhD Position F/M [Campagne DOC MI-NF-LYS-2023] Evaluation of Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening in combination with anti-TIM3 therapeutic antibodies in preclinical mathematical model of Glioblastomas
</title>
        <link rel="icon" type="image/x-icon" href="../../../../favicon-16x16.png"/>
        <script type="text/javascript" src="../../../../js/jquery/jquery-1.9.1.js"></script>
        <script type="text/javascript" src="../../../../css/bootstrap-3.3.4/js/bootstrap.js"></script>
        	<meta property="og:description" content="Offre d'emploi Inria" />
	<meta property="og:title" content="PhD Position F/M [Campagne DOC MI-NF-LYS-2023] Evaluation of Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening in combination with anti-TIM3 therapeutic antibodies in preclinical mathematical model of Glioblastomas" />
	<meta property="og:url" content="http://jobs.inria.fr/public/classic/fr/offres/2023-06029" />
	<meta property="og:locale" content="fr_FR" />
	<meta property="og:site_name" content="Inria"/>
	<meta property="og:type" content="article" />
        	            <link rel="stylesheet" href="../../../../css/bootstrap-3.3.4/css/bootstrap.min.css"/>
            <link rel="stylesheet" href="../../../../library/bootstrap-select-1.12.2/dist/css/bootstrap-select.min.css"/>
            <link rel="stylesheet" href="../../../../css/bootstrap/bootstrap-datetimepicker.css"/>
            <link rel="stylesheet" href="../../../../library/font-awesome-4.7.0/css/font-awesome.css"/>
            <link rel="stylesheet" href="../../../../css/fonts/fonts.css"/>
            <link rel="stylesheet" href="../../../../css/app/main_public.css" />
            <link rel="stylesheet" href="../../../../css/inria.css"/>
        
	<link property="stylesheet" rel="stylesheet" href="../../../../css/app/detailOffre.css" />
    </head>
<body  style="background-image: url('../../../../images/bg-jobs.png') ">
    
<nav id="toplinklist" class="nav navbar-nav navbar-default navbar-fixed-top" >
    <div class="navbar-inner">
        <div class="container">
            <div class="navbar-header">
                                <a href="../offres.html" class="pull-left inriatoplinklogo">
                    <img alt="Inria" width="30%" src="https://commons.inria.fr/images/logo/inr_logo_sans_sign_rouge.jpg" />
                </a>
                                <button type="button" class="navbar-toggle toplinktoggle" data-toggle="collapse" data-target="#navbar-collapse-menuTop">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse" id="navbar-collapse-menuTop">
                <ul class="nav navbar-nav navbar-right">
                                        <li class="visible-xs text-right toplinktoggle-remove nav-profil-menu" data-toggle="collapse" data-target="#navbar-collapse-menuTop">
                        <i class="inria-gray3 fa fa-remove fa-2x"></i></li>
                    <li class=" text-center picto-lang nav-profil-menu" >
                                                                         <span class="toplang-button">
                             <a class="a-inria" href="2023-06029.html" >FR</a> <span class="inria-gray2">|</span>
                             <a class="inria-gray2" href="../../en/offres/2023-06029.html" title="English">
                                EN
                            </a>
                        </span>
                                            </li>

                                                                                                    <li class="dropdown text-center nav-profil-menu">
                        <a href="2023-06029.html#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">
                            <img alt="user" src="../../../../images/user.png">
                                                        <p style="color: black;">
                                Compte <span class="caret"></span>
                            </p>
                                                    </a>
                        <ul class="dropdown-menu">
                                                        <li><a href="../../../fr/connect.html"> <span class="fa fa-sign-in"></span> Se connecter</a></li>
                            <li><a href="../../../fr/register.html"><span class="fa fa-plus"></span> Créer un compte</a></li>
                                                    </ul>
                    </li>
                                </ul>
            </div><!-- /.navbar-collapse -->
          </div><!-- /.container -->
    </div><!-- /.navbar-inner -->
</nav>


<!-- Bouton Scroll -->
<div class="row">
    <div class="col-md-12">
        <div class="visible-sm visible-xs">
            <a href="2023-06029.html#" title="Haut de page" class="scrollup scrollup-sm link-btn" type="button">
                <i class="fa fa-chevron-up"></i>
            </a>
        </div>
        <div class="visible-md">
            <a href="2023-06029.html#" title="Haut de page" class="scrollup scrollup-md link-btn" type="button">
                <i class="fa fa-chevron-up"></i>
            </a>
        </div>
        <div class="visible-lg">
            <a href="2023-06029.html#" title="Haut de page" class="scrollup scrollup-lg link-btn" type="button">
                <i class="fa fa-chevron-up"></i>
            </a>
        </div>
    </div>
</div>
<!-- Main content -->
<div class="col-md-12 main-content" style="height:auto;">
    <div class="row">
        <div class="col-xs-10 col-xs-offset-1 col-lg-8 col-lg-offset-2 menu-breadcrumb">
            <a href="https://jobs.inria.fr/public/classic/fr/offres?locale=fr" class="a-inria">
        Accueil
        </a>
         > 
        <a href="https://jobs.inria.fr/public/classic/fr/offres?locale=fr" class="a-inria">Liste des offres</a>
         > Détail d&#039;une offre        </div>
    </div>
    <div class="row" ><div  class="col-xs-10 col-xs-offset-1 col-md-8 col-lg-6 col-lg-offset-2"></div></div>
<div class="row">
    <div class="col-md-12 col-lg-10 col-lg-offset-1">
        <div class="row">
                    
                <div id="left" class="col-sm-7 col-lg-6 col-lg-offset-1 block-left">
                    <div class="list-group list-group-item" style="padding: 6%; font-size: 16px;">
                                              <div class="row">
                            <span class="h4-inria intitule-detail-offre col-xs-10 col-sm-11"> 
                                <b>2023-06029 - PhD Position F/M [Campagne DOC MI-NF-LYS-2023] Evaluation of Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening in combination with anti-TIM3 therapeutic antibodies in preclinical mathematical model of Glioblastomas</b>
                            </span>
                            <span class=" col-xs-2 col-sm-1">
                            <a class="a-inria" class="pdf-link"  href="https://jobs.inria.fr/public/classic/fr/offres/2023-06029/topdf" title="PDF">
                            	<i class="fa fa-file-pdf-o fa-2x pull-right"></i>
                            </a>
                            </span> 
                        </div>
                        <div class="row">
                         <span class=" h4 col-xs-10 col-sm-11"> 
                                                                                   <i class="fa fa-info-circle"></i> <em>Le descriptif de l’offre ci-dessous est en Anglais</em>
                                                                               </span>
                        </div>
                                						
		<div class="grand-item-offre">
		
				<div class="item-offre">	    	
	    	<p class="list-group-item-text"><b>Type de contrat : </b>
	        	CDD
	        </p>	        
	    </div>
	    	    
	    	    
	    	    <div class="item-offre">
	    	<p class="list-group-item-text"><b>Niveau de diplôme exigé : </b>
	        	Bac + 5 ou équivalent
	        </p>
	    </div>
	    	    
	    	    
	    	    
	    		<div class="item-offre">
	    	<p class="list-group-item-text"><b>Fonction : </b>
	        	Doctorant
	        </p>
	    </div>
	    	    
	    	    
	    	    
	        </div>
    
        
        <div class="grand-item-offre">
    	<h4 class="list-group-item-heading">A propos du centre ou de la direction fonctionnelle</h4>
    	<div class="list-group-item-text text-justify">
    		<p>The Inria research centre in Lyon is the 9th Inria research centre, formally created in January 2022.&nbsp; It brings together approximately 300&nbsp;people in 16 research teams and research support services.</p>
<p>Its staff are distributed at this stage on 2 campuses: in Villeurbanne La Doua (Centre / INSA Lyon / UCBL) on the one hand, and Lyon Gerland (ENS de Lyon) on the other.</p>
<p>The Lyon centre is active in the fields of software, distributed and high-performance computing, embedded systems, quantum computing and privacy in the digital world, but also in digital health and computational biology.</p>
    	</div>
    </div>
        
        <div class="grand-item-offre">
    	<h4 class="list-group-item-heading">Contexte et atouts du poste</h4>
    	<div class="list-group-item-text text-justify">
    		<p>This thesis will take place at Inria Lyon, located on the Campus La Doua, in collaboration with:</p>
<ul>
<li><span lang="fr-FR">Annabelle Ballesta (Researcher Inserm, Paris):&nbsp;Sensitivity analysis and parameter estimation:&nbsp;<a href="https://institut-curie.org/personne/annabelle-ballesta">https://institut-curie.org/personne/annabelle-ballesta</a></span></li>
<li><span lang="fr-FR">Ahmed Idbaih (Onco-neurology, H&ocirc;pital Piti&eacute;-Salp&ecirc;tri&egrave;re, Paris)&nbsp;et&nbsp;</span>Mait&eacute; Verreault (biologist, H&ocirc;pital Piti&eacute;-Salp&ecirc;tri&egrave;re, Paris):&nbsp;Glioblastoma experiment in mice, treated with anti-TIM3 antibody plus LIPU-MBO: <a href="https://www.esmo.org/about-esmo/profiles/ahmed-idbaih">https://www.esmo.org/about-esmo/profiles/ahmed-idbaih</a></li>
</ul>
<p>The person recruited will travel regularly to Paris (on average one day per month) to collaborate with our onco-neurologists and biologists partners.</p>
    	</div>
    </div>
        
        <div class="grand-item-offre">
    	<h4 class="list-group-item-heading">Mission confiée</h4>
    	<div class="list-group-item-text text-justify">
    		<p align="JUSTIFY"><span lang="en-US"><strong>Motivation and biological context</strong></span></p>
<p align="JUSTIFY">Glioblastoma (GBM) is the most frequent primary malignant tumors of the central nervous system. These infiltrating tumors are associated with an extremely poor prognosis. Immunotherapy by direct stimulation of the immune system with immune checkpoint blockade (ICB), as anti-PD1 and anti-PDL1 therapeutic antibodies, are effective treatments for multiple malignancies but most of GBM patients do not respond to this immunotherapeutic approach.</p>
<p>Several reasons are associated with resistance of GBM to ICB: (i) low immunogenicity -i.e. low mutational burden-, (ii) immunosuppressive microenvironment and, (iii) the blood brain barrier (BBB) limiting drug penetration.&nbsp;Indeed, the BBB is a biophysical and biochemical obstacle for ICB to reach their target. Preclinical and clinical studies showed that ultrasound mediated BBB opening (UMBO) using low-intensity pulsed ultrasound (LIPU) is a safe and effective method to enhance delivery of therapeutic agents to the brain in preclinical and clinical settings.&nbsp;In preclinical models of GBM, efficacy of anti-PDL1 therapeutic antibody is enhanced when administered in combination with LIPU. LIPU increase the delivery of anti-PDL1 antibody to the brain and the tumor, and activate microglia cells. This combination doubled the number of long-term survivors compared to anti-PDL1 administration alone. &nbsp;In the same line, more recently T cell immunoglobulin domain and mucin domain protein 3 (TIM3) has been shown to be the most common co-inhibitory immune checkpoints in GBM expressed by both tumor and non-tumor cells. In addition, TIM3 has been shown to promote tumor growth.</p>
<p>Therefore, inhibiting TIM3 using anti-TIM3 therapeutic antibody appears as a promising strategy. However, therapeutic antibodies are large molecules that do not cross the BBB spontaneously. Therefore, in the present study, we will evaluate the therapeutic and biologic effects of anti-TIM3 antibodies with and without LIPU-MBO in preclinical mathematical model of GBM to increase their brain bioavailability and anti-tumor activity.</p>
<p><strong>Experimental materials and methods (Data)</strong></p>
<p>Our partners will conduct experiments to collect data, they will use two syngeneic GBM mouse models: (i) GL261 and (ii) NFPP10. GL261 is murine GBM and NFPP10 is genetically engineered mouse GBM. Both cells are transduced to express the luciferase allowing noninvasive monitoring of tumor growth. Tumor cells will be engrafted in the right caudate nucleus-putamen of immunocompetent C57BL/6 mice using a stereotactic frame. In both GBM mouse models, TIM3 expression will be assessed using RT-qPCR and immunostaining. Multiplex immunostaining will be performed to identify cell populations expressing TIM3. Tumor bearing mice will be treated with anti-TIM3 antibody plus LIPU-MBO. Several control groups will be used: (i) untreated tumor bearing mice, (ii) tumor bearing mice treated with anti-TIM3 alone and (iii) tumor bearing mice treated with LIPUMBO alone. Each group will include 12 mice. The preclinical trial will be conduct with both GBM models (i.e. GL261 and NFPP10).</p>
<p align="JUSTIFY"><span style="color: #000000;"><span lang="en-US">The endpoints will be: (i) toxicity using limit-points, (ii) anti-tumor efficacy in terms of tumor growth, (iii) anti-tumor efficacy in terms of mice survival, (iv) immune microenvironment modulations and, (vi) brain penetration of anti-TIM3. </span></span></p>
<p align="JUSTIFY"><span style="color: #000000;"><span lang="en-US">The immune microenvironment will be assessed using multiplex immunostaining and FACS sorting. Brain concentration of anti-TIM3 will be assessed using mass spectroscopy.</span></span></p>
<p align="JUSTIFY"><span lang="en-US"><strong>Mathematical modeling</strong></span></p>
<p align="JUSTIFY"><span lang="en-US">We will develop mathematical models for both GBM mouse models,&nbsp;</span><span style="color: #000000;"><span lang="en-US">(i) GL261 and (ii) NFPP10, with and without BHE opening</span></span><span lang="en-US">, based on ordinary differential equations (ODE), delay differential equations (DDE) and structured partial differential equations (PDE). The dynamics of GBM and TIM3 will be studied mathematically in the same scenarios as the experiments: (i) untreated tumor-bearing mice, (ii) tumor-bearing mice treated with anti-TIM3 alone, and (iii) tumor-bearing mice treated with LIP-UMBO alone. </span><span style="color: #000000;"><span lang="en-US">Once the data are available, we will proceed to estimate the model parameters. Analysis of the stability of equilibria and their bifurcation as a function of model parameters (in the autonomous case). Variation of the frequency and duration of opening of the UMBO and its impact on the efficiency of the treatment. Numerical simulation of solutions in different scenarios.</span></span></p>
<p align="JUSTIFY"><span lang="en-US"><strong>Expected results</strong></span></p>
<p align="JUSTIFY"><span lang="en-US">We hypothesize that LIPU-MBO administration will enhance the efficacy of anti-TIM-3 antibodies against in vivo preclinical models of GBM and will be the rational for combining anti-TIM3 with other therapeutic strategies and the rational for a clinical trial in GBM patients.&nbsp;Based on the mathematical model, we will study the best therapeutic strategy combining the use of LIPU-MBO and the administration of anti-TIM-3 antibodies.</span></p>
    	</div>
    </div>
        
        <div class="grand-item-offre">
    	<h4 class="list-group-item-heading">Principales activités</h4>
    	<div class="list-group-item-text text-justify">
    		<p>The work will follow the following steps:</p>
<p>Bibliographic study, state of the art of cancer modeling and its pharmacokinetic/pharmacodynamic treatment.&nbsp;</p>
<p>Construction of a mathematical model in the four scenarios: untreated tumor-bearing mice, tumor-bearing mice treated with anti-TIM3 alone, tumor-bearing mice treated with LIP-UMBO alone, and tumor-bearing mice treated with LIP-UMBO and anti-TIM3. &nbsp;</p>
<p>Model parameter estimation and sensitivity analysis.</p>
<p>Mathematical and numerical analysis of the models.</p>
<p>References</p>
<ul>
<li><strong>Idbaih A </strong>et al.<strong>&nbsp;</strong>Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening Increases Anti-Programmed Death-Ligand 1 Delivery and Efficacy in Gl261 Mouse Model. Pharmaceutics. 2023 Jan 30;15(2):455.</li>
<li><strong>Verreault M</strong>, <strong>Idbaih A&nbsp;</strong>et al. Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma. J Neurooncol. 2019 Aug;144(1):33-41.</li>
<li><strong>Idbaih A</strong>, et al. Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial. Neuro Oncol. 2023 Jan 5;25(1):123-134.</li>
<li><strong>Idbaih A</strong>, et al. Safety and Feasibility of Repeated and Transient Blood-Brain Barrier Disruption by Pulsed Ultrasound in Patients with Recurrent Glioblastoma. Clin Cancer Res. 2019 Jul 1;25(13):3793-3801.</li>
<li><strong>Idbaih A </strong>et al.&nbsp;Clinical trial of blood-brain barrier disruption by pulsed ultrasound. Sci Transl Med. 2016 Jun 15;8(343):343re2.</li>
<li><strong>Idbaih A</strong>, et al. Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter. Neuro Oncol. 2022 Nov 2;24(11):1935-1949.</li>
<li>Da Silva G, Da Silva ICR,&nbsp;<strong>Adimy M</strong>, Mancera PFA. A Mathematical Model for Treatment of Papillary Thyroid Cancer Using the Allee Effect. Journal of Biological Systems. 28(3), 701-718 (2020)</li>
<li>Da Silva G, Da Silva ICR,&nbsp;<strong>Adimy M</strong>, Mancera PFA.&nbsp;The effect of lenvatinib and pembrolizumab on thyroid cancer refractory to iodine 131I simulated by mathematical modeling. Journal of Biological Systems, 30 (01), 93-112 (2022).</li>
<li><strong>Ballesta A</strong>, Zhou Q, Zhang X, Lv H, Gallo JM. Multiscale Design of Cell-Type-Specific Pharmacokinetic/Pharmacodynamic Models for Personalized Medicine: Application to Temozolomide in Brain Tumors. CPT: Pharmacometrics &amp; Systems Pharmacology (2014), 3 e112.</li>
</ul>
    	</div>
    </div>
        
        <div class="grand-item-offre">
		<h4 class="list-group-item-heading">Compétences</h4>
		<div class="list-group-item-text text-justify">
			<div class="page" title="Page 2">
<div class="section">
<div class="layoutArea">
<div class="column">
<ul>
<li>have a degree in mathematics</li>
<li>be familiar with PDEs, ODEs, dynamical systems</li>
<li>be familiar with numerical simulation techniques</li>
<li>be familiar with mathematical modeling applied to biology</li>
</ul>
</div>
</div>
</div>
</div>
		</div>
	</div>
	    
        <div class="grand-item-offre">
    	<h4 class="list-group-item-heading">Avantages</h4>
    	<div class="list-group-item-text text-justify">
    		<ul>
<li>
<ul>
<li>Subsidized&nbsp;meals</li>
<li>Partial reimbursement of public transport costs</li>
<li>Leave: 7 weeks of annual leave + 10 extra days off due to RTT (statutory reduction in working hours) + possibility of exceptional leave (sick children, moving home, etc.)</li>
<li>Possibility of teleworking (90 days / year) and flexible organization of working hours</li>
<li>Social, cultural and sports events and activities</li>
<li>Access to vocational training</li>
<li>Social security coverage under conditions</li>
</ul>
</li>
</ul>
    	</div>
    </div>
        
        <div class="grand-item-offre">
    	<h4 class="list-group-item-heading">Rémunération</h4>
    	<div class="list-group-item-text text-justify">
    		<p><strong>1st and 2nd year:</strong> 2051 euros gross salary /month<br />&nbsp;<br />&nbsp;<strong>3rd year:</strong> 2158 euros gross salary / month</p>
    	</div>
    </div>
      
                    </div>
                </div>
        
                          <div id="right" class="col-sm-5 bloc-right">	
               
                	<div class="row">
                		<div class="col-sm-12" style="padding:15px;margin-bottom :10px;">
                     	                        	                           		<a href="2023-06029.html#" class="btn btn-lg btn-danger btn-postuler-footer" style="width:100%" data-toggle="modal" data-target="#registerOffre">Postuler</a>
                        	                    			
            			</div>
            		</div>
        		    	<h4 >Partager</h4>

		<ul class="social">
		<li><a target="_blank" href="https://www.facebook.com/sharer.php?u=http://jobs.inria.fr/public/classic/fr/offres/2023-06029&title=Offre+d%27emploi+Inria&description=PhD Position F/M [Campagne DOC MI-NF-LYS-2023] Evaluation of Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening in combination with anti-TIM3 therapeutic antibodies in preclinical mathematical model of Glioblastomas" class="a-facebook btn btn-sm btn-danger"> <i class="fa fa-facebook"></i> </a></li>
		<li><a target="_blank" href="https://www.linkedin.com/shareArticle?mini=true&url=http://jobs.inria.fr/public/classic/fr/offres/2023-06029&title=Offre d'emploi Inria&summary=PhD Position F/M [Campagne DOC MI-NF-LYS-2023] Evaluation of Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening in combination with anti-TIM3 therapeutic antibodies in preclinical mathematical model of Glioblastomas" class="a-linkedin btn btn-sm btn-danger"> <i class="fa fa-linkedin"></i> </a></li>
		<li><a target="_blank" href="http://twitter.com/share?hashtags=Jobs.inria.fr,Emploi,Villeurbanne&text=Offre d'emploi Inria : PhD Position F/M [Campagne DOC MI-NF-LYS-2023] Evaluation of Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening in combination with anti-TIM3 therapeutic antibodies in preclinical mathematical model of Glioblastomas%0A&url=http://jobs.inria.fr/public/classic/fr/offres/2023-06029" class="a-twitter btn btn-sm btn-danger"> <i class="fa fa-twitter"></i> </a></li>
		<li><a target="_blank" href="mailto:?body=Offre d'emploi Inria :%0A PhD Position F/M [Campagne DOC MI-NF-LYS-2023] Evaluation of Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening in combination with anti-TIM3 therapeutic antibodies in preclinical mathematical model of Glioblastomas%0A%0A http://jobs.inria.fr/public/classic/fr/offres/2023-06029&subject=Offre d'emploi Inria: PhD Position F/M [Campagne DOC MI-NF-LYS-2023] Evaluation of Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening in combination with anti-TIM3 therapeutic antibodies in preclinical mathematical model of Glioblastomas" class="a-envelope btn btn-sm btn-danger"> <i class="fa fa-envelope"></i> </a></li>
	</ul>
	
        				
	<h4 >Informations générales</h4>
	<ul class="nomargin">
									<li><strong>Thème/Domaine :</strong>
											Modélisation et commande pour le vivant
						<br/>										
											Biologie et santé, Sciences de la vie et de la terre
													(BAP A)
																
				</li>
							
				<li><strong>Ville :</strong>
			Villeurbanne
		</li>
				
				<li><strong>Centre Inria :</strong>
							<a class="a-inria" target="_blank" href="http://www.inria.fr/centre/lyon">Centre Inria de Lyon</a>
					</li>  
						
					<li><strong>Date de prise de fonction souhaitée :</strong>
				2023-10-01
			</li>
							<li><strong>Durée de contrat :</strong>
					3 ans
				</li>
							
				<li><strong>Date limite pour postuler :</strong>
			2023-04-14				
		</li>
			</ul>
	
        				
	<h4 >Contacts</h4>
	<ul class="nomargin">
				<li><strong>Equipe Inria :</strong>
							<a class="a-inria" href="https://www.inria.fr/equipes/DRACULA" target="_blank">DRACULA</a>    	
								</li>
																			<li>
			<strong>Directeur de thèse :</strong>
			<br/>
			Adimy Mostafa
			/
			<a class="a-inria" href="mailto:mostafa.adimy@inria.fr">mostafa.adimy@inria.fr</a>
		</li>
	    	</ul>

        				
	
        			<div class="grand-item-offre">
    					<h4 class="list-group-item-heading">A propos d&#039;Inria</h4>
    					<p class="list-group-item-text text-justify">
    		            Inria est l’institut national de recherche dédié aux sciences et technologies du numérique. Il emploie 2600 personnes. Ses 200 équipes-projets agiles, en général communes avec des partenaires académiques, impliquent plus de 3500 scientifiques pour relever les défis du numérique, souvent à l’interface d’autres disciplines. L’institut fait appel à de nombreux talents dans plus d’une quarantaine de métiers différents. 900 personnels d’appui à la recherche et à l’innovation contribuent à faire émerger et grandir des projets scientifiques ou entrepreneuriaux qui impactent le monde. Inria travaille avec de nombreuses entreprises et a accompagné la création de plus de 180 start-up. L&#039;institut s&#039;eﬀorce ainsi de répondre aux enjeux de la transformation numérique de la science, de la société et de l&#039;économie.
    					</p>
    				</div>
            			
	<h4 >Consignes pour postuler</h4>
	<div class="text-justify">
		<p>CV, cover letter and Master's grades are expected. One or two letters of recommendation from a professor or master's supervisor will be appreciated.</p>
	</div>
				
	<p class="text-justify">
		<strong>Sécurité défense : </strong>
		<br/>
		Ce poste est susceptible d’être affecté dans une zone à régime restrictif (ZRR), telle que définie dans le décret n°2011-1425 relatif à la protection du potentiel scientifique et technique de la nation (PPST). L’autorisation d’accès à une zone est délivrée par le chef d’établissement, après avis ministériel favorable, tel que défini dans l’arrêté du 03 juillet 2012, relatif à la PPST. Un avis ministériel défavorable pour un poste affecté dans une ZRR aurait pour conséquence l’annulation du recrutement.
    </p>
             	
    <p class="text-justify">
    	<strong> Politique de recrutement :</strong>
        <br/>
		Dans le cadre de sa politique diversité, tous les postes Inria sont accessibles aux personnes en situation de handicap.
    </p>
        <p class="text-justify alert alert-warning">
		<b>Attention</b>: Les candidatures doivent être déposées en ligne sur le site Inria. Le traitement des candidatures adressées par d'autres canaux n'est pas garanti.
    </p>
    
             </div>
        </div>
    </div>
</div>

<!-- Modal Creer son compte -->
<div class="modal fade" id="registerOffre" tabindex="-1" role="dialog" aria-labelledby="myModalLabel">
    <div class="modal-dialog" role="document">
        <div class="modal-content ">
            
            <div class="modal-body">
              	<div class="row">
                  	<div class="col-md-6 pull-right">
                  		<button type="button" class="close" data-dismiss="modal" aria-label="Close"><i class="fa fa-remove"></i></button>
                  	</div>
            	</div>
            	<div class="row">
					<div class="col-md-6">
						<div class="form-group">
                        <p class="h4-inria list-group-item-text text-center">
                        Je crée mon compte
                        </p> 
                        <p class="h4 list-group-item-text text-center "> 
             			<i class="fa fa-info-circle"></i>
             			 Pour suivre votre candidature
                        </p>
            			<p class="h3 list-group-item-text text-center">
                           	<a href="https://jobs.inria.fr/public/fr/register?ref=2023-06029"  class=" btn btn-danger">
	        	        		<i class="fa fa-plus"></i> Créer un compte
           					</a>
        				</p>
             			
                        </div>
       				</div>
           
           			<div class="col-md-6"  style="border-left: 1px solid #CCC;">
           				<div class="form-group">
           			
                        <p class="h4-inria list-group-item-text text-center">
							J&#039;ai déjà un compte!
                        </p> 
            			<p class="h3 list-group-item-text text-center">
                           	<a href="https://jobs.inria.fr/public/classic/fr/offres/2023-06029/postuler"  class=" btn btn-danger">
	        	        		<i class="fa fa-sign-in"></i> Se connecter
           					</a>
        				</p>
        				</div>
       				</div>
            	</div>
        	</div>
            <div class="modal-footer" style="border: none;">
                <button type="button" class="btn btn-default" data-dismiss="modal">Annuler </button>
            </div>
            
        </div>
    </div>
</div>

<script type="text/javascript" src="../../../../library/bootstrap-select-1.12.2/dist/js/bootstrap-select.min.js"></script>
        <script type="text/javascript" src="../../../../js/moment.js"></script>
		<script type="text/javascript" src="../../../../js/bootstrap-datetimepicker.js"></script>
		<script src="../../../../js/cookiechoices.js"></script>
		<script>
				var textCookie = "En poursuivant votre navigation sur ce site vous acceptez l'utilisation des cookies pour vous proposer des contenus et services adaptés à vos centres d'intérêts.";
		var textBtnCookie = 'En savoir plus';
		var textAccept = "J'accepte";
				document.addEventListener('DOMContentLoaded', function(event){cookieChoices.showCookieConsentBar(
				textCookie, textAccept, textBtnCookie, '/public/fr/mentions-legales');
		});
		</script>

		<script type="text/javascript">

		 ScrollToTop = function() {
             var screen = $(window).scrollTop();
             if (screen > 100) {
               $('.scrollup').fadeIn();
             } else {
               $('.scrollup').fadeOut();
             }
         }
		 $('.scrollup').on('mouseover', function(){
             $(this).addClass('scrollup-mouseover');
             $(this).removeClass('scrollup-mouseout');
            });
         $('.scrollup').on('mouseout', function(){
             $(this).addClass('scrollup-mouseout');
             $(this).removeClass('scrollup-mouseover');
            });

         $('.scrollup').on('click',function () {
             $("html, body").animate({ scrollTop: 0 }, 500);

             return false;
         });

         StopAnimation = function() {
            $("html, body").bind("scroll mousedown DOMMouseScroll mousewheel keyup", function(){
                $('html, body').stop();
            });
         }

         $(window).scroll(function() {
             ScrollToTop();
             StopAnimation();
         });

		</script>


        <!-- Piwik -->
                <script type="text/javascript">
          var _paq = _paq || [];
          /* tracker methods like "setCustomDimension" should be called before "trackPageView" */
          _paq.push(['trackPageView']);
          _paq.push(['enableLinkTracking']);
          (function() {
            var u="//piwik.inria.fr/";
            _paq.push(['setTrackerUrl', u+'piwik.php']);
            _paq.push(['setSiteId', '74']);
            var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
            g.type='text/javascript'; g.async=true; g.defer=true; g.src=u+'piwik.js'; s.parentNode.insertBefore(g,s);
          })();
        </script>
                <!-- End Piwik Code -->
    <script type="text/javascript">
    $(document).ready( function(){
        $("postulerOffre").on('click', function(){
            $('#postulerOffre').modal();
        });
    });
    </script>
    
</div>

<footer class="footer">
    <div class="col-md-12 text-center">
            <span class="text-center text-links-footer">
            <a href="../../../fr/contact.html"  target="_blank">Contact</a>&nbsp;&nbsp;|&nbsp;
            <a href="../../../fr/mentions-legales.html" target="_blank">Mentions légales</a>
                        </span>
    </div>
</footer>
<script src="https://commons.inria.fr/bootstrap/ie10-fixup/ie10-viewport-bug-workaround.js"></script><script type="text/javascript" src="../../../../library/bootstrap-select-1.12.2/dist/js/bootstrap-select.min.js"></script>
        <script type="text/javascript" src="../../../../js/moment.js"></script>
		<script type="text/javascript" src="../../../../js/bootstrap-datetimepicker.js"></script>
		<script src="../../../../js/cookiechoices.js"></script>
		<script>
				var textCookie = "En poursuivant votre navigation sur ce site vous acceptez l'utilisation des cookies pour vous proposer des contenus et services adaptés à vos centres d'intérêts.";
		var textBtnCookie = 'En savoir plus';
		var textAccept = "J'accepte";
				document.addEventListener('DOMContentLoaded', function(event){cookieChoices.showCookieConsentBar(
				textCookie, textAccept, textBtnCookie, '/public/fr/mentions-legales');
		});
		</script>

		<script type="text/javascript">

		 ScrollToTop = function() {
             var screen = $(window).scrollTop();
             if (screen > 100) {
               $('.scrollup').fadeIn();
             } else {
               $('.scrollup').fadeOut();
             }
         }
		 $('.scrollup').on('mouseover', function(){
             $(this).addClass('scrollup-mouseover');
             $(this).removeClass('scrollup-mouseout');
            });
         $('.scrollup').on('mouseout', function(){
             $(this).addClass('scrollup-mouseout');
             $(this).removeClass('scrollup-mouseover');
            });

         $('.scrollup').on('click',function () {
             $("html, body").animate({ scrollTop: 0 }, 500);

             return false;
         });

         StopAnimation = function() {
            $("html, body").bind("scroll mousedown DOMMouseScroll mousewheel keyup", function(){
                $('html, body').stop();
            });
         }

         $(window).scroll(function() {
             ScrollToTop();
             StopAnimation();
         });

		</script>


        <!-- Piwik -->
                <script type="text/javascript">
          var _paq = _paq || [];
          /* tracker methods like "setCustomDimension" should be called before "trackPageView" */
          _paq.push(['trackPageView']);
          _paq.push(['enableLinkTracking']);
          (function() {
            var u="//piwik.inria.fr/";
            _paq.push(['setTrackerUrl', u+'piwik.php']);
            _paq.push(['setSiteId', '74']);
            var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
            g.type='text/javascript'; g.async=true; g.defer=true; g.src=u+'piwik.js'; s.parentNode.insertBefore(g,s);
          })();
        </script>
                <!-- End Piwik Code -->
    <script type="text/javascript">
    $(document).ready( function(){
        $("postulerOffre").on('click', function(){
            $('#postulerOffre').modal();
        });
    });
    </script>
</body>
</html>
